Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(3.82) per share. This is a 45.8 percent decrease over losses of $(2.62) per share from the same period last year.
Sports Legislator Ryan Butler Tweets ‘SportRadar And BetWay Have Extended Their Partnership To Give The Sportsbook Access To The $SRAD Marketing Platform As Well As Its Audio Visual Service, Which Includes A “Global Portfolio Of Live Streaming Sports C…
https://twitter.com/ButlerBets/status/1613190157057802242
